| Q37556437 | Acute Coronary Syndrome and Suicide: A Case-Referent Study |
| Q89875358 | Association of lymphocyte-to-monocyte ratio with total coronary plaque burden in patients with coronary artery disease |
| Q55473373 | Characteristics and the average 30-day and 6-month clinical outcomes of patients hospitalised with coronary artery disease in a poor South-East Asian setting: the first cohort from Makassar Cardiac Center, Indonesia. |
| Q64269616 | Clinical characteristics and outcomes of ST-segment elevation myocardial infarction in a low income setting in rural Bangladesh |
| Q47145695 | Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention |
| Q57215006 | Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries |
| Q96133556 | Identification of risk factors of acute coronary syndrome in young patients between 18-40 years of age at a teaching hospital |
| Q99417036 | Impact of infection in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: insight from a multicentre observational cohort from China |
| Q91809890 | Independent Predictors of Cardiac Mortality and Hospitalization for Heart Failure in a Multi-Ethnic Asian ST-segment Elevation Myocardial Infarction Population Treated by Primary Percutaneous Coronary Intervention |
| Q97519740 | Inter-hospital transfers and door-to-balloon times for STEMI: a single centre cohort study |
| Q91979710 | Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox |
| Q96954016 | Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study |
| Q60912371 | Long-term treatment effect and adverse events of a modified jailed-balloon technique for side branch protection in patients with coronary bifurcation lesions |
| Q36328740 | Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment |
| Q39360977 | Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score |
| Q48106123 | Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study. |
| Q57210706 | Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome |
| Q95266024 | Safety and Cumulative Incidence of Major Cardiovascular Events with Ticagrelor in Taiwanese Patients with Non-ST-Segment Elevation Myocardial Infarction: A 12-Month, Prospective, Phase IV, Multicenter, Single-Arm Study |
| Q52682104 | Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study. |
| Q64917653 | Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis. |
| Q38633613 | Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes. |
| Q55217880 | The CAMI-score: A Novel Tool derived From CAMI Registry to Predict In-hospital Death among Acute Myocardial Infarction Patients. |
| Q39728496 | Trends in evidence-based treatment and mortality for ST elevation myocardial infarction in Malaysia from 2006 to 2013: time for real change |